Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.

× No keyword cloud information.

18 in total

1. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease.

Authors: J O Rinne; H Ruottinen; J Bergman; M Haaparanta; P Sonninen; O Solin
Journal: J Neurol Neurosurg Psychiatry Date: 1999-12 Impact factor: 10.154

2. Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.

Authors: P Riederer; W Birkmayer; D Seemann; S Wuketich
Journal: J Neural Transm Date: 1977 Impact factor: 3.575

Review 3. Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors: J M Cedarbaum
Journal: Clin Pharmacokinet Date: 1987-09 Impact factor: 6.447

Review 4. Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors: Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal: J Clin Invest Date: 2006-07 Impact factor: 14.808

5. Dopamine receptors in the Parkinsonian brain.

Authors: U K Rinne; P Lönnberg; V Koskinen
Journal: J Neural Transm Date: 1981 Impact factor: 3.575

Review 6. Anti-parkinsonian drugs today.

Authors: N P Quinn
Journal: Drugs Date: 1984-09 Impact factor: 9.546

7. Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors: U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal: J Neurol Date: 1975-12-02 Impact factor: 4.849

Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.